{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:24:10Z","timestamp":1787840650195,"version":"build-2784847793"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:p>In the current scenario, treatment of Post kala-azar dermal leishmaniasis (PKDL) is intravenous liposomal amphotericin B or oral miltefosine. Over the years, there has been a gradual decline in the efficacy of miltefosine and a rise in permanent loss of vision. Moreover, in non-endemic states of India, miltefosine is not freely available. In view of this, we attempted a two-step regimen of liposomal amphotericin B and itraconazole to treat two patients of PKDL diagnosed on histopathology as well as PCR. We found this treatment to be highly effective with complete recovery.<\/jats:p>","DOI":"10.4103\/jvbd.jvbd_205_24","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T05:00:32Z","timestamp":1739336432000},"page":"248-251","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Reworking the treatment of Indian Post kala-azar dermal leishmaniasis: A two-step therapy"],"prefix":"10.4103","volume":"62","author":[{"given":"Sushruta","family":"Kathuria","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venerology, Safdarjung Hospital and V Vardhaman Mahavir Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugansh","family":"Gautam","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venerology, Safdarjung Hospital and V Vardhaman Mahavir Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niti","family":"Khunger","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venerology, Safdarjung Hospital and V Vardhaman Mahavir Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Sharma","sequence":"additional","affiliation":[{"name":"ICMR-National Institute of Pathology, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Singh","sequence":"additional","affiliation":[{"name":"ICMR-National Institute of Pathology, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"R1-20260422","doi-asserted-by":"crossref","first-page":"e0004138","DOI":"10.1371\/journal.pntd.0004138","article-title":"PKDL\u2013A Silent Parasite Pool for Transmission of Leishmaniasis in Kala-azar Endemic Areas of Malda District, West Bengal, India","volume":"9","author":"Ganguly","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"R2-20260422","article-title":"Operational definitions in kala-azar elimination programme","year":"2021","journal-title":"35342469131627373987.pdf (nvbdcp.gov.in)"},{"key":"R3-20260422","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/ijd.IJD_651_20","article-title":"Epidemiology of PostKala-azar Dermal Leishmaniasis","volume":"66","author":"Ghosh","year":"2021","journal-title":"Indian J Dermatol"},{"key":"R4-20260422","doi-asserted-by":"crossref","first-page":"e0008429","DOI":"10.1371\/journal.pntd.0008429","article-title":"Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India","volume":"14","author":"Goyal","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"R5-20260422","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13071-020-04011-7","article-title":"Report of the Fifth Post-Kala-Azar Dermal Leishmaniasis Consortium Meeting, Colombo, Sri Lanka, 14\u201316 May 2018","volume":"13","author":"Zijlstra","year":"2020","journal-title":"Parasit Vectors"},{"key":"R6-20260422","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/ijd.IJD_264_20","article-title":"Therapeutic Modalities in Post Kala-azar Dermal Leishmaniasis: A Systematic Review of the Effectiveness and Safety of the Treatment Options","volume":"66","author":"Datta","year":"2021","journal-title":"Indian J Dermatol"},{"key":"R7-20260422","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1473-3099(03)00517-6","article-title":"Post-kala-azar dermal leishmaniasis","volume":"3","author":"Zijlstra","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"R8-20260422","doi-asserted-by":"crossref","first-page":"e0012242","DOI":"10.1371\/journal.pntd.0012242","article-title":"A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh","volume":"18","author":"Sundar","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"R9-20260422","journal-title":"WHO_TRS_949_eng.pdf"},{"key":"R10-20260422","doi-asserted-by":"crossref","first-page":"e0174497","DOI":"10.1371\/journal.pone.0174497","article-title":"To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL)","volume":"12","author":"Das","year":"2017","journal-title":"PLoS One"},{"key":"R11-20260422","doi-asserted-by":"crossref","first-page":"201","DOI":"10.25259\/IJDVL_338_20","article-title":"Liposomal amphotericin B is more effective in polymorphic lesions of post kala-azar dermal leishmaniasis","volume":"88","author":"Moulik","year":"2022","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R12-20260422","first-page":"tpmd230640","article-title":"Treatment Outcomes of Single-Dose Liposomal Amphotericin B-Treated Visceral Leishmaniasis Patients and Factors Affecting Outcome in Bihar, India","author":"Siddiqui","year":"2024","journal-title":"Am J Trop Med Hyg"},{"key":"R13-20260422","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/cid\/ciy172","article-title":"Safety and Effectiveness of Short-Course AmBisome in the Treatment of Post-Kala-Azar Dermal Leishmaniasis: A Prospective Cohort Study in Bangladesh","volume":"67","author":"Den Boer","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R14-20260422","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1179\/136485905X514127","article-title":"Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL)","volume":"99","author":"Musa","year":"2005","journal-title":"Ann Trop Med Parasitol"},{"key":"R15-20260422","doi-asserted-by":"crossref","first-page":"e0402623","DOI":"10.1128\/spectrum.04026-23","article-title":"Antimony susceptible Leishmania donovani: evidence from in vitro drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in preand postmiltefosine era","volume":"12","author":"Ghosh","year":"2024","journal-title":"Microbiol Spectr"},{"key":"R16-20260422","doi-asserted-by":"crossref","first-page":"ofad231","DOI":"10.1093\/ofid\/ofad231","article-title":"Safety and Effectiveness of Miltefosine in Post-Kala-Azar Dermal Leishmaniasis: An Observational Study","volume":"10","author":"Sundar","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"R17-20260422","doi-asserted-by":"crossref","first-page":"e0012242","DOI":"10.1371\/journal.pntd.0012242","article-title":"A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh","volume":"18","author":"Sundar","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"R18-20260422","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/infdis\/jiz486","article-title":"Assessing the Efficacy and Safety of Liposomal Amphotericin B and Miltefosine in Combination for Treatment of Post Kala-Azar Dermal Leishmaniasis","volume":"221","author":"Ramesh","year":"2020","journal-title":"J Infect Dis"},{"key":"R19-20260422","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/archderm.1992.01680130133026","article-title":"Efficacy of ketoconazole in post-kala-azar dermal leishmaniasis","volume":"128","author":"Ramesh","year":"1992","journal-title":"Arch Dermatol"},{"key":"R20-20260422","first-page":"392","article-title":"Therapeutic trial of sodium antimony gluconate alone and in combination with ketoconazole in post-kala-azar dermal leishmaniasis","volume":"69","author":"Rathi","year":"2003","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R21-20260422","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0035-9203(96)90134-0","article-title":"Failure of a combination of two antifungal drugs, terbinafine plus itraconazole, in Sudanese post kala-azar dermal leishmaniasis","volume":"90","author":"Khalil","year":"1996","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R22-20260422","doi-asserted-by":"crossref","first-page":"e0186117","DOI":"10.1371\/journal.pone.0186117","article-title":"Efficacy of azole therapy for tegumentary leishmaniasis: a systematic review and meta-analysis","volume":"12","author":"Galvao","year":"2017","journal-title":"PLoS One"},{"key":"R23-20260422","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-4632.2004.02429.x","article-title":"Cutaneous leishmaniasis: successful treatment with itraconazole","volume":"45","author":"Consigli","year":"2006","journal-title":"Int J Dermatol"}],"container-title":["Journal of Vector Borne Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/JVBD.JVBD_205_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:26:31Z","timestamp":1787837191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/JVBD.JVBD_205_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jvbd.jvbd_205_24","relation":{},"ISSN":["0972-9062"],"issn-type":[{"value":"0972-9062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"2024-11-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}